Novo Nordisk today announced the submission of two New Drug Applications (NDAs) to the U.S. Food and Drug Administration (FDA) for oral semaglutide, …

Eli Lilly and Company today announced it will introduce a lower-priced version of Humalog®(insulin lispro injection 100 units/mL) in the U.S. The …

Innovus Pharmaceuticals, Inc., an emerging commercial-stage pharmaceutical company announced that it received approval from Health Canada to market …

The U.S. Food and Drug Administration (FDA) has approved the use of Sanofi’s Soliqua 100/33 (insulin glargine and lixisenatide injection) 100 …

Novo Nordisk recently submitted label updates to the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) for …

The U.S. Food and Drug Administration (FDA) has approved a label update for AstraZeneca’s FARXIGA® (dapagliflozin) and XIGDUO® XR …

The U.S. Food and Drug Administration has approved the use of the 0.5 mL dose of Fluzone® Quadrivalent (influenza vaccine) to include children …

An advisory committee of the Food and Drug Administration (FDA) voted in a tie yesterday on the approval of a novel type 1 diabetes drug which would …